| Project/Area Number |
21591597
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Radiation science
|
|---|
| Research Institution | Kyoto Prefectural University of Medicine |
|---|
Principal Investigator |
YAMAGAMI Takuji 京都府立医科大学, 医学研究科, 講師 (10257537)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
NISHIMURA Tsunehiko 京都府立医科大学, 医学研究科, 特任教授 (70237733)
TANAKA Osamu 京都府立医科大学, 医学研究科, 助教 (70317246)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2009: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Keywords | インターベンショナルラジオロジー(IVR) / 肝動脈 / 塞栓術 |
|---|
| Research Abstract |
After dipping several kinds of embolic agents into solution of anticancer drugs for certain period of time, degree of including anticancer drugs in embolic agents was evaluated. Optimum time for anticancer drugs to be included in embolic agents was led. This research is going on. As a clinical research, trans-hepatic arterial chemo-embolization was performed with combination of several kinds of anticancer drugs and embolic agents such as Gelpart and Embozene. Currently, clinical effectiveness is under evaluation.
|
